| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |